Modelling the natural history of HIV infection in individuals and its epidemiological implications
The variation of viraemia in the natural course of HIV infection is expected to have major influence on the probability of transmission and, consequently, on the epidemiology of HIV/AIDS.
In this paper we propose a model which takes into account the time evolution of HIV viraemia (measured as HIV-RNA copies per ml of blood) in an infected individual and its impact on the threshold for the establishment of an endemic level, and mainly on the relative contribution of each of the clinical phases of the infection to the total transmission of HIV per infected individual.
We consider that an infected individual passes through three phases of viraemia. The first phase, which lasts for 6–7 weeks, is characterized by very high viraemia. In the second phase, which lasts about 10 years, the viraemia is much lower, increasing again in the last phase, which lasts up to two years, and ends in full-blown AIDS.
We show that the relative contribution of each phase to the total transmission of HIV is very sensitive to the model we assume for the dependence of the transmissibility of HIV on the viral load. For instance, if we assume that transmissibility is proportional to the decimal logarithm of viraemia, then the second phase predominates always. Due to the epidemiological importance of this fact, it is clear that further improvement on virological research to better understand the dependence of HIV transmissibility on the viral concentration in biological fluids is necessary.
Unable to display preview. Download preview PDF.
- Ahlgreen, D. J., M. K. Corny and A. C. Stein (1990). Model-based optmization of infectivity parameters: a study of the early epidemics in San Francisco. J. Acquir. Immune Defic. Syndr. 3, 631–642.Google Scholar
- Anderson, R. M. and R. M. May (1991). Infectious Diseases of Humans, Oxford: Oxford Science Publications.Google Scholar
- Arfken, G. (1970). Mathematical Methods for Physicists, 2nd edn, New York: Academic.Google Scholar
- Bagnarelli, P., S. Menzo, A. Manzin, M. Giacca, P. E. Varaldo and M. Clementi (1991). Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. J. Med. Virol. 34, 89–95.Google Scholar
- Bravo, R. et al. (1995). The quantification of human immunodeficiency virus viraemia in patients with rapid and slow progression of the disease. Med. Clin. (Barc.) 104, 530–534.Google Scholar
- Brookmeyer, R. and M. H. Gail (1994). AIDS Epidemiology: A Quantitative Approach, Oxford: Oxford University Press.Google Scholar
- Cameron, D. W., J. N. Simonsen, L. J. D’Costa, A. R. Ronald, G. M. Maitha, M. N. Gakinya, M. Cheang, J. O. Ndinya-Achola, P. Piot and R. C. Brunham (1989). Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 2, 403–407.CrossRefGoogle Scholar
- Connor, R. I., H. Mohri, Y. Cao and D. D. Ho (1993). Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type-1 infected individuals. J. Virol. 67, 1772–1777.Google Scholar
- Dickover, R. E., E. M. Garratty, S. A. Herman, M. S. Sim, S. Plaeger, P. J. Boyer, M. Keller, A. Deveikis, E. R. Stiehm and Y. J. Bryson (1996). Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zydovudine treatment on viral load. JAMA 275, 599–605.CrossRefGoogle Scholar
- Easterbrook, P. J. (1994). Non-progression in HIV infection. AIDS 8, 1179–1182.Google Scholar
- Erb, P., S. Krauchi, D. Burgin, K. Biedermann, C. Camli, C. H. Rudin and the Swiss HIV and pregnancy colaborative study group (1994). Quantitative anti-p24 determinations can predict the risk of vertical transmission. J. Acquir. Immune Defic. Syndr. 7, 261–264.Google Scholar
- Griensven, van, G. J. P., E. M. M. de Vroome, F. de Wolf, J. Goudsmit, M. Roos and R. A. Coutinho (1990). Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men. Am. J. Epidemiol. 132, 203–210.Google Scholar
- Hethcote, H. W. and J. W. Van Ark (1992). Modelling HIV transmission and AIDS in the United States, Berlin: Springer-Verlag.Google Scholar
- Holodniy, M., D. A. Katzenstein, S. Sengupta, A. M. Wang, C. Casipit, D. H. Schwarts, M. Konrad, E. Groves and T. C. Merigan (1991). Detection and quantification of human immunodeficiency virus RNA in patients serum by use of the polymerase chain reaction. J. Infect. Dis. 163, 862–866.Google Scholar
- Houn, H. Y., A. A. Pappas, and E. M. Walker Jr (1987). Status of current clinical tests for human immunodeficiency virus (HIV): applications and limitations. Ann. Clin. Lab. Sci. 17, 279–285.Google Scholar
- Jackson, J. B. and H. H. Balfour Jr (1988). Practical diagnostic testing for human immunodeficiency virus. Clin. Microbiol. Rev. 1, 124–138.Google Scholar
- Jacquez, J. A., J. S. Koopman, C. P. Simon and I. M. Longini Jr (1994). Role of the primary infection in epidemics of HIV infection in gay cohorts. J. Acquir. Immune Defic. Syndr. 7, 1169–1184.Google Scholar
- Jurriaans, S. (1995). Virus load in HIV-1 Infection, PhD thesis, Univerrsity of Amsterdam.Google Scholar
- Keet, I. P. M., P. Krijnen, N. Koot, J. M. A. Lange, F. Miedema, J. Goudsmit and R. A. Coutinho (1993). Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 7, 51–57.Google Scholar
- Koopman, S. J., J. A. Jacquez, W. W. Gavin, C. P. Simon, B. Foxman, M. P. Stephen, D. Barth-Jones, L. A. Andrew and K. Lange (1997). The role of early HIV infection in the spread of HIV through populations. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14, 249–258.Google Scholar
- Lifson, A. R., S. P. Buchbinder, H. W. Sheppard, A. C. Mawle, J. C. Wilber, N. Stanley, C. E. Hart, N. A. Hessol and S. D. Holmberg (1991). Long-term human immunodeficiency virus infection in asymptomathic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J. Infect. Dis. 163, 959–965.Google Scholar
- Mellors, J. W., C. R. Rinaldo Jr, P. Gupta, R. M. White, J. A. Todd and L. A. Kingsley (1996). Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167–1170.Google Scholar
- Piatak, M. J. Jr, M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, P. H. Hahn, G. M. Shaw and J. D. Lifson (1993). High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749–1759.Google Scholar
- Plummer, F. A., J. N. Simonsen and D. W. Cameron et al. (1991). Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 163, 233.Google Scholar
- Sano, K. and M. H. Lee (1987). Antibody that inhibits human immunodeficiency virus reverse transnriptase and association with inability to isolate virus. J. Clin. Microbiol. 25, 2415–2417.Google Scholar
- Simmonds, P. (1990). Variation in HIV virus load of individuals at different stages in infection: possible relationship with risk of transmission. AIDS 4(Suppl. 1), S77–S83.Google Scholar
- Simonsen, J. N., D. W. Cameron, M. N. Gakinya, J. O. Ndinya-Achola, L. J. D’Costa, P. Karasira, M. Cheang, A. R. Ronald, P. Piot and F. A. Plummer (1988). Human immunodeficiency virus infection among men with sexually transmitted disease. Experience from a center in Africa. N. Engl. J. Med. 319, 274–278.CrossRefGoogle Scholar